Mi Chen

This inventor holds 29 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Neurocrine Biosciences, Inc., Dart Neuroscience, (Cayman) Ltd.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Chen. Retrieved from https://idiyas.com/inventor/mi-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 9)

% Patents Active = 55.2

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 74(Granted Patents)

Company Filing History:

11 out of 991

Chugai Seiyaku Kabushiki Kaisha

patents

9 out of 123

Neurocrine Biosciences, Inc.

patents

4 out of 41

Dart Neuroscience, (Cayman) Ltd.

patents

4. 3 out of 33

Crinetics Pharmaceuticals, Inc.

patents

5. 2 out of 16

Dart Neuroscience, LLC

patents

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Somatostatin Agonists

PDE7 Inhibitors

Gonadotropin-Releasing Hormone

GlyT1 Inhibitors

Malonyl-CoA Decarboxylase

Piperazine Compounds

Coumarin Derivatives

Therapeutic Agents

Imidazole Derivatives

Metabolic Modulators

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12600709 - Nonpeptide somatostatin type 5 receptor agonists and uses thereof (2026-04-14),

2. 12319702 - Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors (2025-06-03),

3. 12134610 - Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof (2024-11-05),

4. 11713324 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2023-08-01),

5. 11685745 - Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors (2023-06-27),

6. 11479540 - Nonpeptide somatostatin type 5 receptor agonists and uses thereof (2022-10-25),

7. 10941159 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2021-03-09),

8. 10336769 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2019-07-02),

9. 10040759 - Substituted azetidinyl compounds as GlyT1 inhibitors (2018-08-07),

10. 9708334 - Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors (2017-07-18),

11. 9624200 - Therapeutic piperazines (2017-04-18),

12. 9422310 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2016-08-23),

13. 8952161 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2015-02-10),

14. 8927546 - Therapeutic piperazines (2015-01-06),

15. 8507536 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2013-08-13),

Title: The Innovative Journey of Mi Chen

Introduction: Mi Chen, a talented inventor based in San Diego, CA, has been making significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Mi Chen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Mi Chen has led numerous successful projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout her career, Mi Chen has collaborated with top research institutions, leading companies, and brilliant minds in the field, fostering a culture of innovation and excellence.

Conclusion: Mi Chen's dedication to pushing the boundaries of technology and her relentless pursuit of innovation make her a true trailblazer in the world of inventions. Her work continues to inspire and shape the future of various industries.

Profile summary based on public USPTO records.